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The human polo-like kinase PLK1 coordinates mitotic chromosome segregation by phosphorylating 
multiple chromatin- and kinetochore-binding proteins. How PLK1 activity is directed to specific 
substrates via phosphopeptide recognition by its carboxyl-terminal polo-box domain (PBD) is poorly 
understood. Here, we combine molecular, structural and chemical biology to identify a determinant 
for PLK1 substrate recognition that is essential for proper chromosome segregation. We show that 
mutations ablating an evolutionarily conserved, Tyr-lined pocket in human PLK1 PBD trigger cellular 
anomalies in mitotic progression and timing. Tyr pocket mutations selectively impair PLK1 binding 
to the kinetochore phosphoprotein substrate PBIP1, but not to the centrosomal substrate NEDD1. 
Through a structure-guided approach, we develop a small-molecule inhibitor, Polotyrin, which occupies 
the Tyr pocket. Polotyrin recapitulates the mitotic defects caused by mutations in the Tyr pocket, 
further evidencing its essential function, and exemplifying a new approach for selective PLK1 inhibition. 
Thus, our findings support a model wherein substrate discrimination via the Tyr pocket in the human 
PLK1 PBD regulates mitotic chromosome segregation to preserve genome integrity.
The human polo-like kinase 1 (PLK1) is a key regulator of chromosome segregation during mitosis, through its 
essential biological functions in chromosome condensation1, cohesin dissociation from chromosomes2, mitotic 
entry3, centrosome maturation4, kinetochore function5, spindle assembly6,7, and exit from mitosis8–10. These dis-
parate functions are mediated through the phosphorylation of proteins that bind to chromatin, centrosomes or 
kinetochores. How these multiple roles can be precisely choreographed during chromosome segregation remains 
unclear, but mounting evidence suggests that PLK1 substrate recognition plays a key role. Thus, human PLK1 
adopts a structure11 that consists of an amino (N-)terminal kinase catalytic domain, with two repeats of the 
so-called ‘polo box’ motif juxtaposed to form a single functional unit called the Polo-Box Domain (PBD) posi-
tioned at the carboxyl (C-) terminus. A similar architecture is adopted by the related human polo-like kinases 
PLK2, PLK3 and PLK4, which also contain a structurally related PBD. The PBD recognizes phospho (p)Ser/Thr 
protein substrates for the kinase catalytic activity of PLKs12. Such PBD substrates are typically primed by a prior 
phosphorylation event catalyzed by other kinases such as CDK113, or in some cases, by PLK1 itself14,15. Several 
lines of evidence indicate that phosphoprotein substrate recognition by the PBD is coordinated with substrate 
phosphorylation by the kinase catalytic domain to determine the spatio-temporal dynamics of PLK1 localisation 
and function during chromosome segregation12,16–18.
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The crystal structure of a substrate peptide in complex with the human PLK1 PBD12 reveals that pSer/Thr 
residues in the phosphopeptide substrate bind to a groove between the two polo boxes, with the phosphate moiety 
making contacts with two crucial residues, His 538 and Lys 540 in the PBD. Mutations in the PBD that preclude 
these key contacts (H538A and K540M) disrupt phosphopeptide substrate engagement and the cellular functions 
of PLK119. How substrate residues other than pSer/pThr dictate substrate discrimination to choreograph PLK1 
function during chromosome segregation remains an important unresolved issue, however.
Intriguingly, recent crystallographic studies have identified a hydrophobic pocket within the human PLK1 
PBD, located adjacent to the phosphosubstrate binding groove, which may regulate substrate recognition. The 
pocket is evident only in certain structural conformers, suggesting that it may adopt an open conformation in 
which it could accommodate residues from PLK1 substrates, or alternatively, a closed conformation precluding 
such interactions20. Seven hydrophobic amino acid residues line the pocket; whilst V415, L478, and F482 cover 
the bottom of the pocket, the Tyr residues Y417, Y421, Y481 and Y485, form its sides20. We find that these Tyr 
residues are conserved across eukaryotic members of the polo-like kinase family, prompting us to term this struc-
tural feature the “Tyr pocket”. The proximity of the Tyr pocket to the phosphosubstrate binding groove, and its 
ability to adopt an open conformation, suggest that it may assist in the recognition of PBD substrates that contain 
hydrophobic side chains, enabling substrate discrimination. For instance, the Tyr pocket is involved in the bind-
ing of a peptide derived from the PLK1 substrate, PBIP120, which contains an Phe71 residue that engages the Tyr 
pocket, as well as with peptidic ligands or chemical fragments that bind to the PBD21–25. However, the functional 
significance of PLK1 substrate recognition via the Tyr pocket during mitotic chromosome segregation remains 
uncertain.
We have therefore combined molecular, structural and chemical biology to address this question. Here, we 
report that the Tyr pocket of the PLK1 PBD exerts an essential function in regulating the timing of progression 
through mitosis. We distinguish a PLK1 substrate that engages the Tyr pocket (PBIP1) from another that does not 
(NEDD1). We also identify a small-molecule chemical ligand for the Tyr pocket that recapitulates chromosome 
segregation defects induced by genetic mutations that ablate the pocket. Collectively, our results suggest a model 
in which the Tyr pocket engages non-phosphorylated residues in phosphoprotein substrates to choreograph 
PLK1 activity during chromosome segregation. Our results also provide a structural and functional rationale 
for targeting the Tyr pocket to create selective chemical inhibitors that modulate substrate recognition by the 
polo-like kinases.
Results
Mutations ablating the Tyr pocket of the PLK1 PBD inhibit viability. We first devised an exper-
imental system in which to address the functional significance of the Tyr pocket of the PLK1 PBD. Structural 
modelling of the Tyr pocket defined three point mutations - Y421 to A, L478 to A and Y481 to D – predicted to 
ablate the Tyr pocket whilst preserving the structural integrity of the nearby phospho-substrate binding groove 
(Fig. 1A and Methods). Accordingly, we used site-directed mutagenesis to create full-length human PLK1 har-
bouring these three mutations (GFP-PLK1AAD), and (N)-terminally fused to enhanced green fluorescent protein 
(GFP). For comparison, we also created plasmids encoding similar GFP-tagged PLK1 constructs encoding the 
wild-type protein (GFP-PLK1Wt), or a well-characterized PLK1 mutant protein harbouring mutations (H538 to 
A, and K540 to M) affecting residues critical for the phospho-substrate binding groove (GFP-PLK1AM) (Fig. 1B). 
Three HeLa cell lines inducibly expressing either GFP-PLK1Wt, GFP-PLK1AM or GFP-PLK1AAD upon exposure to 
doxycycline (Dox) were created using single integration into a defined genomic locus (with the Flp-InTM T-RExTM 
system). These cells inducibly express wild-type or mutant PLK1 proteins as detected by immunoblotting or flu-
orescence microscopy (Supplementary Fig. S1).
Next, we depleted endogenous PLK1 expression in these cell lines using short-interfering (si)RNAs directed 
against the 3′ untranslated region (UTR) of the PLK1 transcript (Table S2), which is absent from the constructs 
encoding GFP-PLK1Wt, GFP-PLK1AM or GFP-PLK1AAD. Indeed, in cells treated with siRNA against the PLK1 
3′ UTR, and induced to express GFP-PLK1 by exposure to a pulse of 0.1 mg.ml−1 Dox, we confirmed that 
GFP-PLK1Wt, GFP-PLK1AAD or GFP-PLK1AM proteins were expressed between 24–48 h of induction, although 
endogenous PLK1 was no longer detectable (Supplementary Fig. S2). As a control, we confirmed that both endog-
enous and GFP-PLK1 expression can be depleted using siRNAs (Table S2) directed against a region of the PLK1 
transcript present in both the endogenous and induced species (Supplementary Fig. S2).
PLK1 is essential for progression through the cell cycle, and it is well established that siRNA-mediated deple-
tion of endogenous PLK1 suppresses cell division26–28. We therefore tested whether Dox-induced expression of 
wild-type or mutant GFP-PLK1 proteins could complement defects in cell proliferation triggered by depletion 
of endogenous PLK1. As expected, GFP-PLK1Wt could complement suppressed cell proliferation, whereas the 
GFP-PLK1AM mutant, in which the phospho-substrate binding groove has been ablated, did not. Interestingly, 
the GFP-PLK1AAD mutant protein, in which the Tyr pocket has been ablated, also did not support cell viability 
(Fig. 1C). These observations suggest that the Tyr pocket of the PLK1 PBD is essential for progression through 
the cell cycle.
Mutations ablating the Tyr pocket of the PLK1 PBD perturb the dynamics of its intracellular 
localisation during the cell cycle. PLK1 exhibits a distinctive pattern of localisation and redistribu-
tion to different sub-cellular structures during the cell cycle, decorating centrosomes29,30, kinetochores13,31–33, 
spindle mid-zone fibers34,35, and the cytokinetic midbody34,36, during distinct cell cycle phases. Mutations viti-
ating the phospho-substrate binding groove of the PLK1 PBD are reported to perturb the dynamics of PLK1 
localisation17,37, suggesting that substrate recognition via the PBD is responsible for its intracellular localisa-
tion. Consistent with this notion, the localisation of GFP-PLK1Wt to kinetochores (Fig. 2A,B) and centrosomes 
(Fig. 2A–C) mirrors that reported for endogenous PLK1 protein30. In contrast, GFP-PLK1AM is decreased at 
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kinetochores (Fig. 2A,B) as previously reported38, but persists at centrosomes (Fig. 2A–C)18,37, distinguishing 
the contribution of substrate recognition by the PBD to these mitotic structures. Similarly, GFP-PLK1AAD exhib-
its reduced accumulation on CREST-stained kinetochores (Fig. 2A,B), although its localisation to centrosomes 
(Fig. 2A–C and Supplementary Fig. S3) remains unimpaired. PLK1 is recruited to centrosomes via the interaction 
of its PBD to multiple phosphoproteins39–41. Thus, our finding that both GFP-PLK1AM and GFP-PLK1AAD retain 
their centrosomal localisation suggests that these mutations do not grossly perturb the folding of the mutant 
C.
B.
KD PBDGFP
A.
Phospho -substrate
binding groove Tyrosine pocket
GFP-PLK1Wt
GFP-PLK1AAD
GFP-PLK1AM
GFP-PLK1Wt GFP-PLK1AAD GFP-PLK1AM
(a) (b)
KD PBDGFP
KD PBDGFP
MQSpTPL FDPPLHSpTA
Figure 1. Mutations ablating the Tyr pocket of the PLK1 PBD inhibit cell viability. (A) The polo-box domain of 
PLK1 in complex with (a) the consensus sequence phosphopeptide MQSpTPL from PDBID 1Q4K and (b) the 
PBIP1 phosphopeptide FDPPLHSpTA from PDBID 3P37. The protein is represented as grey ribbons. The two 
phosphopeptides are displayed in space-filling with green and cyan heavy atoms respectively. The tyrosine pocket 
residues Tyr421, Leu478, and Tyr481 are labelled and displayed in space-filling with magenta heavy atoms. Only 
polar hydrogens are shown. (B) A schematic showing GFP -tagged PLK1Wt/AAD/AM used in the study. KD = Kinase 
Domain, PBD = Polo-Box Domain. (C) The graph shows cell viability of GFP-PLK1Wt/AAD/AM (as indicated) at the 
end of 48 h after transfection of siRNA and induction with doxycycline measured using CellTiter-Blue® reagent. 
The overexpression of GFP-PLK1Wt but not GFP-PLK1AAD or GFP-PLK1AM is able to completely overcome 
the viability defect caused by the knockdown of endogenous PLK1 using siPLK1 3′UTR (see arrowheads). 
As expected, silencing of both overexpressed GFP-PLK1Wt/AAD/AM as well as the endogenous PLK1 has 
deleterious effects on cell viability. Each bar is a mean of 3 replicates ± S.D.
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PBDs, or their ability to bind at least a subset of substrates. Remarkably however, both mutants decrease local-
isation to kinetochores, which again involves PBD interaction with different phosphoprotein partners5,33,42,43, 
suggesting that the mutations selectively perturb PBD interactions with other substrates.
Mutations ablating the Tyr pocket of the PLK1 PBD impair mitotic progression. PLK1 deple-
tion using siRNA, or inhibition of its enzymatic activity using chemical inhibitors, triggers mitotic arrest and 
defects in chromosome segregation8,26,44,45. We therefore tested the contribution of the Tyr pocket to these func-
tions. As expected, depletion of endogenous PLK1 protein induces mitotic arrest, marked by a sharp increase 
(range, 31.7–34.7%) in the percentage of cells stained for the mitotic marker, phospho-histone H3 (pH3). Induced 
expression of GFP-PLK1Wt overcomes mitotic arrest, reducing the percentage of pH3-stained mitotic cells to 
9 ± 0.8%. However, neither the GFP-PLK1AM nor GFP-PLK1AAD mutant could overcome mitotic arrest induced 
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Figure 2. Mutations ablating the Tyr pocket of the PLK1 PBD perturb the dynamics of its intracellular 
localisation during the cell cycle. (A) Representative maximal-intensity projections of kinetochores (KT) in 
red, centrosomes (CENT) in white, GFP-PLK1Wt/AAD/AM in green and DNA in blue used for quantification 
of GFP-PLK1 intensity in (B,C). Cells were treated with Dox (0.5 mg.ml−1) for 7 h, fixed and stained for 
kinetochores with CREST antiserum, centrosomes with anti-Pericentrin and DNA with Hoechst 33342 and 
analysed by immunofluorescence microscopy for GFP signal in prophase mitotic cells. Segmentation images 
show computationally generated segmentations of the DNA (blue), KTs (red) and CENTs (white) used for 
analysis. Scale bar is 5μm on top panel and 1μm in bottom panel. The images were smoothed, and brightness 
and contrast settings are constant throughout. (B) Quantification of intensity ratios of GFP-PLK1Wt/AAD/AM on 
CREST-stained kinetochores (KT) normalized to the corresponding GFP-PLK1 expression in cells. Data from 
each cell is represented as a hollow circle, horizontal line (red) indicates mean intensity ratio and error bars 
indicate ± S.D. Statistical analysis was done using non-parametric, Mann-Whitney two-tailed test with 95% 
confidence interval, ***p < 0.0001, ns = not significant. (C) Quantification of intensity ratios of GFP-PLK1Wt/
AAD/AM on Pericentrin-stained Centrosomes (CENT) normalized to the corresponding GFP-PLK1 expression 
in cells. Data from each cell is represented as a hollow circle, horizontal line (red) indicates mean intensity ratio 
and error bars indicate ± S.D. Statistical analysis was done using non-parametric, Mann-Whitney two-tailed 
test with 95% confidence interval, ns = not significant.
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Figure 3. Mutations ablating the Tyr pocket of the PLK1 PBD impair mitotic progression. (A) HeLa cell 
lines inducibly expressing GFP-PLK1Wt/AAD/AM were treated with siPlk1 3′UTR both with ( + ) and without 
(−) Dox or BI2536 or Poloppin as indicated and fixed 24 h later. The fixed cells were stained for spindle 
microtubules (β-tubulin) and DNA and analysed by microscopy. Mitotic cells were identified by spindle 
organisation and chromatin condensation, and scored under three categories viz., (1) monopolar spindles and 
misaligned chromosomes; (2) bipolar spindles with misaligned chromosomes; and (3) bipolar spindles with 
aligned chromosomes. Data is from two independent experiments, totalling at least 200 cells per condition. 
Quantification of cellular phenotype in each category in the histogram is represented as mean ± S.D. Treatments 
with BI2536 and Poloppin were included as control for categories (1) and (2) respectively. (B) Representative 
images of each category (as in A) used for scoring cells are shown. Scale bar 5μm. (C) Live cell time-lapse 
images of GFP-PLK1Wt/AAD/AM expressing cells transfected with SiPlk1 3′UTR. Time in hours (h) before (−0.5 h) 
and after Nuclear Envelope Breakdown (NEBD) (t = 0.0 h) to late anaphase (green arrow)/ death (red arrow) is 
shown for each cell. Scale bar, 5μm. The images presented are representative of two independent experiments. 
(D) Duration in mitosis (h) from NEBD to late anaphase/ death, in single cell GFP-PLK1Wt/AAD/AM cells by 
live cell imaging. Each filled-in square represents data from a single cell and those which complete mitosis are 
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by depletion of endogenous PLK1, indicating that the Tyr pocket as well as the phospho-substrate binding groove 
of the PBD are essential for this function (Supplementary Fig. S4).
More subtle distinctions between the contributions of PLK1 kinase activity versus the phospho-substrate 
binding groove and the Tyr pocket of the PBD domain are suggested by overexpression studies. Previous work 
has shown that small molecule inhibition of PLK1 kinase activity results in mitotic arrest with monopolar spin-
dles, whereas inhibition of the PBD domain causes bipolar spindles with misaligned chromosomes38,45,46. Thus, 
depletion of endogenous PLK1 protein causes monopolar spindle arrest with defects in chromosome congres-
sion (74.3 ± 6.4%) (Fig. 3A,B). Induced expression of either GFP-PLK1Wt, or the PBD mutants GFP-PLK1AAD 
or GFP-PLK1AM, counteracted these defects in differing ways. Induced expression of GFP-PLK1Wt counteracts 
defects in both chromosome congression and bipolar spindle formation, with 48 ± 4.3% cells showing normal 
chromosomal congression with bipolar spindles (Fig. 3A). However, while GFP-PLK1AAD or GFP-PLK1AM 
overexpression restores bipolar spindle formation (respectively in 78.5 ± 2.5% or 78.5 ± 1.5% of cells), it is less 
effective in counteracting chromosome congression defects, with only 11.5 ± 0.7% or 5.5 ± 0.7% of cells respec-
tively showing normal chromosomal congression (Fig. 3A). These results suggest that the Tyr pocket and the 
phospho-substrate binding groove of the PBD are both essential for normal chromosome congression but not 
bipolar spindle formation, whereas PLK1 kinase activity is essential for both processes.
We therefore analysed PLK1-depleted cells overexpressing either GFP-PLK1AAD or GFP-PLK1AM by single-cell 
imaging to discern mitotic progression. As expected, PLK1-depleted cells entered mitosis but did not complete 
division and instead, undergo prolonged arrest (6.5–9.13 h) before cell death (Fig. 3C,D). Induced expression of 
GFP-PLK1Wt but not GFP-PLK1AAD or GFP-PLK1AM mutants overcomes the defect, permitting normal mitotic 
exit (Fig. 3C,D and Supplementary videos M1–3), confirming that the PLK1 PBD is essential for this process.
During mitosis, cells overexpressing GFP-PLK1AAD or GFP-PLK1AM mutants maintain a prometaphase arrest 
accompanied by significant chromosomal movement and failure to align chromosomes on the metaphase plate 
(Fig. 3C). However, cells overexpressing GFP-PLK1AAD persist longer in mitosis (11.5 h) before cell death com-
pared to cells overexpressing GFP-PLK1AM (7.1 h) (Fig. 3D). Collectively, these observations raise the possibility 
that the phospho-substrate binding groove and Tyr pocket make distinct, but essential, contributions during 
chromosome segregation.
Differential engagement of PLK1 PBD substrates via the Tyr pocket. Dynamic analysis of 
GFP-PLK1 recruitment to mitotic structures using fluorescence recovery after photobleaching (FRAP) reveals 
differences in the function of the phospho-substrate binding groove and the Tyr pocket of the PBD. FRAP meas-
ures the speed and extent of the recovery of fluorescence at specific regions within living cells, after photobleach-
ing of these regions with an intense but brief pulse of laser light (Supplementary Fig. S5). As previously reported37, 
differences in the speed of fluorescence recovery from GFP-PLK1Wt and GFP-PLK1AM (Fig. 4A, median time 
to 50% recovery (t1/2) 0.7 s (GFP-PLK1Wt) or 0.3 s (GFP- PLK1AM) are consistent with the faster diffusion of the 
GFP-PLK1AM mutant protein, which cannot bind tightly to PBD substrates. In other words, the slow fluorescence 
recovery exhibited by GFP-PLK1Wt indicates that its diffusion is limited by binding to other proteins such as PBD 
substrates, whereas the rapid fluorescence recovery of the GFP-PLK1AM mutant is consistent with the loss of 
binding to PBD substrates37. Notably, however, fluorescence recovery by the GFP-PLK1AAD mutant occurred with 
kinetics slower than GFP-PLK1AM (medians t1/2 0.4 s vs t1/2 0.3 s respectively; p = 0.015, Mann-Whitney test) 
but more rapid than GFP-PLK1Wt (median t1/2 0.4 s vs 0.7 s; p = 0.013; Mann-Whitney test). This observation 
suggests that mutations ablating the Tyr pocket may affect PLK1 binding to some, but not all, PBD substrates.
We tested this possibility using a biochemical approach. The canonical PLK1 PBD substrate, NEDD1 (Neural 
precursor cell Expressed Developmentally Downregulated gene1), is a centrosomal protein primed by CDK1 
phosphorylation47 to bind the PBD during mitotic progression48. Consistent with this interaction, we find that 
GFP-PLK1Wt can be co-immunoprecipitated with NEDD1 in extracts prepared from cells synchronized in mitosis 
(Fig. 4B, final right-hand lane, and Supplementary Fig. S6). Anti-NEDD1 reproducibly detects a modest but clear 
signal in the coimmunoprecipitates (relative intensity 0.2, normalized to its respective input lane). In contrast, the 
GFP-PLK1AM mutant fails to interact with NEDD1 under similar conditions (relative intensity 0). Interestingly, 
GFP-PLK1AAD retains binding to NEDD1 (relative intensity 0.2), demonstrating that the PLK1-NEDD1 interac-
tion during mitosis is mediated via the phospho-substrate binding groove - but not the Tyr pocket - of the PBD. 
This observation accords with FRAP data wherein GFP-PLK1AM shows faster recovery than GFP-PLK1AAD than 
GFP-PLK1Wt.
We have previously shown by X-ray crystallography that the Tyr pocket of the PBD may adopt an open con-
formation in which certain phosphopeptide substrates containing hydrophobic residues that contact the Tyr 
pocket are accommodated20. One such substrate is PBIP1 (Polo-Box Interacting Protein 1), in which a phos-
phopeptide motif surrounding pThr78 binds to the PLK1 PBD to mediate its recruitment to the kinetochores33. 
We have previously shown in a crystal structure of PLK1 PBD bound to the PBIP1 phosphopeptide Phe(7
1)-Asp-Pro-Pro-Leu-His-pThr(78)-Ala that the hydrophobic residue, Phe71, contacts the Tyr pocket in the open 
conformation20.
We therefore used a biochemical approach to test the contribution made by the Tyr pocket in the PLK1-PBIP1 
interaction during mitosis. Owing to the lack of a suitable commercially available antibody against PBIP1, we 
shown in green while those which undergo death are in red. The horizontal line indicates mean time (h) spent 
in mitosis before cell death. Statistical analysis was with Mann-Whitney two-tailed t-test; ns, not significant; 
***p = 0.0003 to 0.0007; ****p < 0.0001. The total number of cells followed in each condition is 22. The data 
presented is representative of two independent experiments.
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Figure 4. Differential engagement of PLK1 PBD substrates via the Tyr pocket. (A) FRAP analysis of interphase 
centrosomes in live cells. GFP-PLK1Wt/AAD/AM at the centrosome was photobleached and its recovery monitored 
at 0.2 s intervals. The median t1/2 time taken for 50% maximal recovery for GFP-PLK1Wt/AAD/AM were found 
to be 0.7 s, 0.4 s and 0.3 s respectively. The arrowhead indicates the point of photobleaching. An inset shows 
data points for the first 5 seconds including photobleaching and recovery time of GFP signal. (B) HeLa cells 
expressing GFP-PLK1Wt/AAD/AM were synchronized in mitosis by double thymidine block and released as shown 
in the experimental schedule. The cell lysates were immunoprecipitated using GFP-Trap® beads to pull down 
GFP-PLK1Wt/AAD/AM and analysed by immunoblotting. The data presented is representative of two independent 
experiments. (C) HeLa cells expressing GFP-PLK1Wt/AAD/AM were transfected with PBIP1Wt-V5 or pcDNA™3.1/
V5-HisA vector (or V5 vector) and harvested 24 h later. PBIP1Wt-V5/ V5 was pulled down from the lysates 
using V5 antibody and immunoprecipitates were analysed by immunoblotting. Asterisks (*) indicate cross-
reacting bands. The data presented is representative of two independent experiments. (D) HeLa GFP-PLK1Wt 
overexpressing cells were transfected with either PBIP1Wt/F71A/T78A-V5 or V5 vector and harvested 24 h later. 
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generated a carboxyl (C)-terminal V5 epitope-tagged PBIP1Wt construct (PBIP1Wt -V5), and over-expressed this 
tagged protein in cells harbouring either GFP-PLK1Wt, or the GFP-PLK1AM or GFP-PLK1AAD mutants. Whereas 
PBIP1-V5 co-immunoprecipitates with GFP-PLK1Wt protein, it does not bind to the GFP-PLK1AM phosphosite 
mutant (Fig. 4C). Similarly, the interaction of PBIP1Wt -V5 with the GFP-PLK1AAD mutant is greatly reduced 
(Fig. 4C). Reciprocal co-immunoprecipitation using an anti-GFP antibody shows that neither mutant can be 
detected in complex with PBIP1 (Supplementary Fig. S7), again consistent with greatly reduced interaction 
under these conditions. Thus, our results demonstrate an essential role for the PBD Tyr pocket in mediating the 
PLK1-PBIP1 interaction during mitosis.
To test whether the Phe71 residue in PBIP1 engenders a critical contact with the PBD Tyr pocket, we tested 
whether a mutant form of PBIP1-V5 in which Phe71 was mutated to Ala (PBIP1-F71A-V5) could bind to 
GFP-PLK1 proteins in the cellular milieu. As a control, we used a mutant form of PBIP1-V5 in which the phos-
phorylated residue, pThr78, was substituted with the non-phosphorylable amino acid Ala (PBIP1-T78A-V5), 
vitiating its ability to bind PLK1 PBD33. Indeed, the interaction of both the PBIP1-F71A-V5 (relative intensity 0.7) 
and PBIP1-T78A-V5 (relative intensity 0.1) mutants with GFP-PLK1Wt in the cell extracts was markedly reduced 
when compared with wildtype PBIP1-V5 (relative intensity 2.5) (Fig. 4D). These results provide further evidence 
that engagement of the PBD Tyr pocket by Phe71 is essential for the PBIP1-PLK1 interaction during mitosis.
A small-molecule inhibitor targeting the Tyr pocket in PLK1 PBD recapitulates pocket muta-
tions. Next, we used molecular modelling to design inhibitors that would block phosphopeptide recogni-
tion by the PBD. The chemical synthesis and characterization of one such molecule, Polotyrin, are described in 
Supplementary Methods. Polotyrin (Fig. 5A) inhibits the binding of a TAMRA-labelled PBIP1 phosphopeptide 
(Glu-Thr-Phe(71)-Asp-Pro-Pro-Leu-His-pThr(78)-Ala) to recombinant PLK1 PBD protein in a dose-dependent 
manner, with an IC50 of 115 ± 24 µM (Fig. 5B). To verify its binding pose, we soaked the molecule into PBD crys-
tals and determined the structure of the complex. While designed to be a phospho-peptide mimetic, Polotyrin 
was found (Supplementary Figure S3) to occupy the Tyr pocket, with the iodophenyl moiety occupying the Tyr 
pocket and the thiophene ring stacking against Tyr481 (Fig. 5C). The binding opens the pocket, flipping both Tyr 
481 and Tyr417 out of its way, akin to what a long PBD-binding phosphopeptide would do (Fig. 5D). The termi-
nal group of Polotyrin, with an aromatic bi-carboxylic acid, makes limited interactions with the domain and is 
poorly resolved in the electron density, and does not engage with the phospho-Ser/Thr interaction site. Given this 
unexpected binding mode, we confirmed the binding of Polotyrin by soaking the crystals with an analogue of the 
Tyr-binding iodophenyl group, 3-iodobenzyl bromide. This fragment bound in the Tyr pocket in identical pose 
to Polotyrin (Fig. 5D), opening the pocket by shifting the two tyrosines. These findings confirm the binding site 
and binding mode for Polotyrin, as well as the Tyr pocket’s affinity for a iodophenyl group. The conformation of 
the Tyr pocket lining residues in Polotyrin and 3-iodobenzyl bromide complexes are virtually identical to those 
found in PBD in complex with the long FDPPLHSpTA peptide20. Thus, Polotyrin exemplifies a small-molecule 
inhibitor of phospho-substrate engagement with the PLK1 PBD via the Tyr pocket.
The cellular phenotypes elicited by Polotyrin exposure are consistent with its proposed mechanism of action. 
Polotyrin causes a dose-dependent increase in mitotic arrest in HeLa cells (Fig. 5E), marked by an increase 
in staining for the marker phospho-histone H3. Mitotic arrest is accompanied by characteristic anomalies in 
chromosome congression (Supplementary Fig. S8). Finally, Polotyrin treatment reproducibly but only slightly 
decreases the co-immunoprecipitation of PBIP1Wt-V5 with GFP-PLK1Wt in cell extracts (Fig. 5F), consistent with 
the effects of mutation of F71A in PBIP1 (Fig. 4D). Thus, Polotyrin exhibits biological effects supporting its mech-
anism of action in the PLK1 Tyr pocket, albeit at relatively high doses consistent with its modest in vitro potency 
(IC50 ~115 µM), warranting further chemical optimization in future studies.
Discussion
How the mitotic kinase PLK1 precisely recognizes and modifies multiple substrates to regulate sequential steps 
in chromosome segregation remains unclear. The findings we report here combine molecular, structural and 
chemical biology to define a previously unrecognized, novel function in chromosome segregation for a recently 
identified structural feature - the Tyr pocket – in the human PLK1 PBD. We provide a first line of evidence that 
the Tyr pocket plays an essential cellular role in the recognition of a class of PLK1 PBD substrates exemplified 
by PBIP1, distinct from those, like NEDD1, whose recognition depends solely on the previously characterized 
substrate binding groove (Fig. 6). Finally, we exploit this information to present evidence that small-molecule 
inhibitors targeting the Tyr pocket suffices to abrogate specific functions of PLK1 in dividing cells. Our findings 
have several important implications.
Our findings show for the first time that ablation of the Tyr pocket severely disrupts substrate recognition by 
the PLK1 PBD. Thus, the GFP-PLK1AM or GFP-PLK1AAD mutants exhibit defects in cell proliferation and mitotic 
progression, and in the localisation of PLK1 to kinetochores. These findings not only demonstrate that the Tyr 
pocket is essential for the cellular functions of PLK1, but also suggest that it does not play second fiddle to the 
well-characterized phosphosubstrate binding groove in substrate recognition.
Indeed, our findings strongly support the idea that a certain class of PLK1 PBD substrates, which may pos-
sess hydrophobic residues that engage the Tyr pocket adjacent to the key pSer/pThr, depend for their recogni-
tion on the integrity of this structural feature. Thus, PLK1Wt binds to both the canonical substrates NEDD1 and 
PBIP1Wt/F71A/T78A-V5 was pulled down from the lysates using V5 antibody and analysed by immunoblotting. 
Asterisks (*) indicate cross-reacting bands. The data presented is representative of two independent 
experiments.
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Figure 5. Targeting the Tyr pocket of the PLK1 PBD with a small-molecule inhibitor, Polotyrin. (A) The 
chemical structure of Polotyrin and 3-iodobenzyl bromide. (B) Polotyrin competitively inhibits the binding 
of a TAMRA- labelled-Glu-Thr-Phe(71)-Asp-Pro-Pro-Leu-His-pThr(78)-Ala-Ile-Tyr-Ala-Asp-Glu-acid 
phosphopeptide to the PLK1 PBD in Fluorescence Polarisation assay. (C) Crystal structure of PBD (surface 
rendering) with Polotyrin (stick model with yellow carbon atoms) shows how the compound binds in the Tyr-
pocket that opens up on binding to long PBD substrates. Phosphopeptide FDPPLHSpTA from PBIP1 spanning 
the from Tyr pocket to the phospho-substrate binding groove is shown as transparent sticks for reference 
(PDB 3p37). (D) Complex of alpha-bromo-2-iodo-tolune (stick model with pale yellow carbons) bound to 
PBD with side chains of the aromatic residues aligning the Tyr pocket are shown as thin sticks (pale yellow). 
Tyr pocket lining residues from Polotyrin (yellow), FDPPLHSpTA (white) and LHSpTA (blue) complexes are 
also shown as well to illustrate structural changes in the pocket on binding to different ligands. (E) HeLa cells 
were treated with Polotyrin (at 1000, 800, 400, 200, 100 & 50 μM) and BI2536 (100 nM) for 24 h. Mitotic cells 
were scored as phospho-histone H3 positive cells and expressed as a percentage of the total number of Hoechst 
33342-stained nuclei using a high-content screening platform as described earlier55. Each bar is a mean of three 
replicates ± S.D. and shows a dose-dependent increase in mitotic index upon treatment with Polotyrin; data 
from DMSO-treated cells is shown as a broken line. The data presented is representative of two independent 
experiments. Statistical analysis was done using Mann-Whitney two-tailed t-test; **p = 0.0029 to 0.0057; 
****p < 0.0001. (F) HeLa GFP-PLK1Wt cells were transfected with PBIP1Wt-V5 and harvested 24 h later. The 
lysates were incubated with Polotyrin (2 mM) or DMSO. PBIP1Wt-V5 was pulled down using V5 antibody and 
co-immunoprecipitates were analysed by immunoblotting.
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PBIP1, whilst PLK1AAD binds only to NEDD1, but PLK1AM binds neither substrate (Fig. 4A–C). The potential 
functional significance of differential substrate recognition via the Tyr pocket is highlighted by several observa-
tions. Differences in the kinetics of fluorescence recovery after photobleaching exhibited by the GFP-PLK1AAD, 
GFP-PLK1AM and GFP-PLK1Wt proteins suggests that their capacity for substrate binding is in the order 
PLK1Wt > PLK1AAD > PLK1AM (Fig. 4A), consistent with our biochemical experiments. Moreover, our observa-
tion that cells overexpressing GFP-PLK1AAD persist for longer in mitosis before undergoing cell death when com-
pared to those overexpressing GFP-PLK1AM (Fig. 3D), as well as differences in mitotic progression between these 
settings, speak to the same conclusion, highlighting the importance of the Tyr pocket in the mitotic functions 
of human PLK1. Thus, our findings suggest a model in which the Tyr pocket acts in concert with the substrate 
binding groove to fine-tune the selective recognition of specific PLK1 substrates involved in mitotic progression.
A number of small-molecule inhibitors that disrupt protein-protein interactions of the PLK1 PBD with its 
cognate protein substrates have been developed46,49–52, although several of the earlier compounds are non-specific 
protein alkylators39. Furthermore, peptide-modified ligands have been developed which additionally span up to 
the Tyrosine pocket25,51. Here, we identify a novel small-molecule inhibitor, Polotyrin, which binds to the Tyr 
pocket (Fig. 5C). The cellular phenotypes elicited by Polotyrin are consistent with our conclusion from somatic 
cell genetics that targeting the Tyr pocket of PLK1 causes mitotic arrest (Fig. 5E), although further optimisation 
will be necessary to improve Polotyrin’s cellular activity. Thus, these findings provide proof-of-principle, and a 
structural blueprint, for the future design of a novel class of PLK1 inhibitors that modulate substrate recognition 
by the PLK1 PBD by targeting the Tyr pocket. Future studies using such chemical tools promise to enhance 
understanding of how PLK1 precisely coordinates the recognition and phosphorylation of multiple proteins that 
bind chromatin, centrosomes or kinetochores to regulate chromosome segregation during mitosis.
KD PBD KD PBD
KD PBD KD PBD
KD PBDKD PBD
 PLK1 Wild-type (PLK1Wt)
Protein ‘X’
Protein ‘Y’
Protein ‘P’
PLK1 Tyr pocket mutant (PLK1AAD)
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Binds to all PBD 
substrates;
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Binds to PBD 
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those like 
Protein ‘P’;
affects progression 
through mitosis 
Does not bind to 
PBD substrates;  
affects progression 
through mitosis 
Figure 6. A model for the role of PLK1-Tyr pocket in differential substrate recognition and mitotic progression. 
The two classes of PBD phospho-substrates are shown as (1) those including proteins ‘X’ and ‘Y’ (e.g. NEDD1) 
and (2) others containing a hydrophobic amino acid residue proximal to the pS/pT residue, shown here as 
protein ‘P’ (e.g. PBIP1). PLK1Wt binds to both categories of PBD-substrates; PLK1AAD does not bind to protein 
‘P’-like substrates while PLK1AM binds none.
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Methods
Cloning and transfection. GFP-Plk1AAD was generated by sequential site-directed mutagenesis of GFP-
Plk1Wt (M. Daniels, Oxford University) using oligonucleotides in Supplementary Table S1. Plk1 from Plk1Wt, 
Plk1AM25 and Plk1AAD were amplified using primers in Table S1 using AccuPrime Pfx DNA polymerase 
(ThermoFisher Scientific) following manufacturer’s instructions and cloned at XhoI and NotI restriction sites in 
pcDNA5/TO/FRT/GFP-Mps1 (kind gift from Professor Steve Taylor, University of Manchester) replacing Mps1 
with Plk1.
Oligonucleotides (Supplementary Table S1) were used to amplify PBIP1Wt from PBIP1 I.M.A.G.E. cDNA 
clone (Source Bioscience) using AccuPrime Pfx DNA polymerase as above. PBIP1Wt was cloned in pcDNA™3.1/
V5-HisA vector (ThermoFisher Scientific) at BamHI and XbaI restriction sites. This PBIP1Wt-V5 construct was 
then used to generate PBIP1F71A-V5 and PBIP1T78A-V5 by site-directed mutagenesis using oligonucleotides in 
Supplementary Table S1. All clones used in the study were verified by Sanger Sequencing (Source Bioscience). 
DNA transfection to generate stable cell lines was  performed as described earlier53. Transfection of constructs 
(PBIP1Wt/F71A/T78A) was done using Lipofectamine 2000 (Invitrogen) according to manufacturers’ instructions. 
siRNA duplexes were purchased from Qiagen and MWG (Supplementary Table S2). SiRNA transfections were 
carried out at a concentration of 25 nM using DharmaFECT1 (Dharmacon, GE Healthcare) following manufac-
turer’s instructions.
Molecular modelling of tyrosine pocket mutations. Structural analysis was performed on the PLK1 
PBD complexed with the FDPPLHSpTA phosphopeptide from PBIP1 (PDBID 3P37). The protein structure 
was downloaded from the Protein Databank. Selenomethionines were changed to methionines and missing 
sidechains were added using Schrodinger’s Preparation Wizard, which was also used to check the orientations 
of the asparagine, glutamine, and histidine residues as well as the protonation state of all ionizable residues. All 
heteroatomic species such as buffer solvents and ions were removed. The hydrogen-atom positions were then built 
using Schrodinger’s Preparation Wizard and the force field parameters and partial charges were assigned from the 
OPLS force field54. Crystallographic water molecules were deleted.
Structural analysis was then performed to identify residues which could be mutated to abrogate phosphopep-
tide binding to the Tyrosine pocket but retain phosphopeptide binding to the phosphopeptide binding groove. 
Tyr417, Tyr421, Tyr481, and Tyr485 form the sides of the pocket. Val415 and Phe482 form the base of the pocket. 
Leu478 forms the back of the pocket. Val415, Tyr417, Phe482, and Tyr485 are relatively close to the phosphopep-
tide binding groove (all within 7 Angstroms of the backbone carbonyl of the −3 residue). Conversely, Tyr421, 
Leu478, and Tyr481 are approximately 10, 14, and 11 Angstroms from the backbone carbonyl of the −3 residue 
respectively (see Fig. 1A). These residues were selected for computational mutagenesis.
To avoid a combinatorial explosion, each of the three residues was mutated to only four other amino acids: 
alanine, serine, asparagine, and aspartate. These were selected for their small size. All 124 mutants were gen-
erated and the complexes with the FDPPLHSpTA phosphopeptide optimized using Schrodinger’s Embrace in 
each case. Predicted binding free energies between the PBD and the phosphopeptide were then estimated using 
Schrodinger’s MMGBSA approach41. Binding affinities were compared with the wild-type and the triple mutant 
Y421A/L478A/Y481D was selected as the most deleterious to FDPPLHSpTA phosphopeptide binding with a 
single change in charge.
Cell culture, generation of stable cell lines and chemical treatments. HeLa FlpInTM T-RExTM host 
cells (kind gift from Professor Steve Taylor, University of Manchester) were used for generating stable cell lines. 
The cells were grown at 37 °C under 5% CO2 in DMEM with GlutaMAX (Life Technologies), supplemented 
with 10% fetal calf serum, ZeocinTM (Invitrogen) at 0.05 mg.ml−1 and Blasticidin (InvivoGen) at 4 μg.ml−1. 
Medium containing Hygromycin (InvivoGen) at 0.2 mg.ml−1 and Blasticidin were used for selection and main-
tenance of resistant clones which were pooled and expanded. For all experiments unless specified, doxycycline 
(Sigma-Aldrich) at 0.1 mg.ml−1 was used for induction of GFP-fusion protein.
For synchronisation, cells were arrested in early S-phase with Thymidine (Sigma, 2 mM) for 16 h, then released 
for 8 h in Thymidine-free medium, these were then arrested again with Thymidine for 16 h followed by release. 
As and where specified an overnight treatment with Nocodazole (Sigma) at 40 nM, BI2536 (Axon Medchem) at 
100 nM and Poloppin41,46, at 100 µM was given.
Immunoblotting and analysis. For immunoblotting, proteins were extracted in lysis buffer containing 
50 mM HEPES (pH7.4), 100 mM NaCl, 0.5% NP-40, 10 mM EDTA, 20 mM β-glycerophosphate, 1 mM DTT, 
1 mM sodium orthovanadate, 1 mM PMSF, protease inhibitor cocktail and phosphatase inhibitor (Roche). 
Extracts were resolved by SDS-PAGE, transferred to PVDF membrane. Ponceau S (Sigma-Aldrich) staining was 
done on the membrane prior to blocking to visualise uniform transfer of the samples. The membrane was blocked 
with TBS-Tween (50 mM Tris pH 7.6, 150 mM NaCl, 0.1% Tween-20) plus 5% non-fat dried milk, and probed 
with primary antibodies overnight at 4 °C. Following that, the membrane was washed in TBS-Tween and incu-
bated in secondary antibodies for 1 h at room temperature. The membrane was washed in TBS-Tween and signal 
was developed using ECL or ECL prime reagent (GE Healthcare). The intensity of protein bands in pull down 
experiments was quantified using ImageJ. For this, a region of interest (ROI) was created around a protein band 
in a grayscale image, and band intensity was measured. For each blot, the same frame (ROI) was used to make 
measurements of protein bands across all the lanes including the background. The pixel intensities were inverted 
for each band (255 – measured band intensity) including background. Net signal intensity was obtained by sub-
tracting inverted background intensity. Normalised band intensity (as seen in figures) was expressed by taking a 
ratio of net signal intensity of IP band over its input control.
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cell viability assay. Cells were seeded in 96-well plates at a density of 4000 cells per well in 100 µl of medium 
without antibiotics, 16 h later treated with doxycycline and siRNA simultaneously and the medium was replaced 
the next day. CellTiter-Blue®reagent (Promega) was diluted (1:10) and added to the medium 48 h after transfec-
tion. The plates were incubated at 37 °C for 2 h in the dark in a humidified 5% CO2 incubator. Cell viability was 
determined by increase in fluorescence signal using a plate reader with filter sets 590 ± 20/540 ± 20 (PheraStar, 
BMG).
Immunofluorescence and image analysis. Cells were grown and fixed on μ-slides (Ibidi, 80826) with 
4% formaldehyde (Agar Scientific) for 10 min. Cells were permeabilised with 0.1% Triton-100 (ThermoFisher 
Scientific), 0.1% Tween-20 (NBS Biologicals) in 1x PBS (PBS-Triton-Tween) for 10 min and blocked with 1% 
BSA (ThermoFisher Scientific) in PBS-Triton-Tween for 30 min. Antibodies were diluted in the blocking solution 
and cells were incubated in the dark for 1 h at room temperature. The cells were washed thrice with the blocking 
solution, and incubated with Alexa FluorTM conjugated secondary antibodies (Life Technologies) in the dark for 
30 min at room temperature. The cells were washed twice with the blocking solution, and stained for 2 minutes 
with Hoechst 33342 (1:4000 diluted in 1XPBS, Invitrogen) and washed twice with 1X PBS. The samples were 
stored at 4 °C in the dark before microscopy. For Fig. 3A,B, mitotic phenotypes were counted manually under the 
microscope, and representative images were taken on a LeicaSP5 confocal microscope using a 100×1.4 NA/oil 
objective. For sub-cellular localisation of GFP-PLK1Wt/AAD/AM (Fig. 2), the images were captured using a Zeiss880 
confocal microscope using a Plan-apochromat 100×/1.46 NA oil objective with z-stacks of confocal slices taken 
at 0.5 μm intervals. Pixel intensities were never saturated and laser exposure and detector settings were identi-
cal between samples across an experiment. To computationally measure GFP-PLK1 levels at centrosomes and 
kinetochores on a per cell basis, maximum intensity projections of four colour 3D data were analysed in Cell 
Profiler. Segmentation of DNA by Hoechst 33342 staining was used to create a mask within which anti-CREST 
foci denoting kinetochores were detected by thresholding. Centrosomes marked by anti-PCNT staining were 
simultaneously detected within segmented cytoplasmic or nuclear regions of the same cells. To correct for varia-
bility in GFP-PLK1 expression level, values were normalized to mean cellular levels in the cytoplasm and nucleus. 
Segmentation was manually checked for accuracy.
Mitotic index (MI) assay. MI assay was either performed in high content screening format as described in55 
or by manually counting the phospho-histoneH3 staining per 100 Hoechst stained nuclei under the microscope.
Live cell imaging. For time-lapse analysis, cells were plated in a chambered glass-bottom plate (Lab-Tek 
Chambered coverglass, catalogue no. 155383), transfected with siRNA and imaged in a heated chamber (37 °C 
and 5% CO2) using a 40×/0.5 NA objective on Leica Live cell microscope. Images were recorded every 5 min for 
up to 40 h. Data from live cells was analysed using Leica Lite AF software, between 16–33 h of siRNA transfec-
tion and induction of GFP-PLK1Wt/AAD/AM. Time in mitosis was determined from nuclear envelope breakdown 
(NEBD) to late anaphase.
FRAP and image analysis. FRAP was essentially as described in Mahen et al.39, with some modifications. 
Cells were imaged in L15 CO2 independent media (Gibco) at 37 °C, in μ-slides (see above) on a Zeiss 880 con-
focal microscope with a Plan-apochromat 63×/NA 1.4 oil objective. One confocal slice was imaged with a pixel 
size of 0.082 µm × 0.082 µm × 1 µm in the x-y-z dimension respectively, with each image taking 0.2 s to acquire. 
Bleaching took 0.4 s in a circle of area 3.19 µm2 using 100% power of a 488 nm argon laser. Regions of interest were 
defined in Zen Black software and analysis was performed with EasyFRAP56 making corrections for background 
fluorescence and image bleaching. t1/2 s were calculated by fully normalising the data and fitting with a single 
exponential term as described in56.
Co-Immunoprecipitation (co-IP). 0.5 to 2.0 mg of lysates was used for co-IP. GFP-pull down was per-
formed using 10 μl GFP-Trap® (Chromotek) as per manufacturer’s instructions. V5 antibody was pre-incubated 
with G-beads (Dynabeads, Invitrogen) as per manufacturer’s instructions. V5-beads were incubated with the 
lysates for 2 h at 4 °C on a rotator to pull down PBIP1Wt/F71A/T78A-V5. Incubation with Polotyrin (2 mM) and 
corresponding control DMSO was done at this stage. The immune-complexes were washed thrice with the lysis 
buffer and denatured using LDS loading buffer (Invitrogen) and heating at 70 °C prior to resolving on SDS-PAGE.
Antibodies. The following antibodies were used for immunoblotting or immunoflourescence; PLK1 
(Invitrogen 33-1700; 1:1000), CREST (Europa, 1:1000), Pericentrin (Abcam 4448; 1:500) β-tubulin 
(Sigma-Aldrich D66; 1:1000), GFP (Clontech JL-8 632381; 1:1000), V5 (Invitrogen R96025; 2ul for IP & 1:5000 
for immunoblotting) PhosphoS10-histone H3 (Abcam 14955; 1:2500), Nedd1 (Abcam 57336; 1:1000), β-actin 
(Sigma-Aldrich A5441; 1:10000), HRP-conjugated Mouse/Rabbit/ L-chain specific (Jackson ImmunoResearch 
Laboratories, Inc., 1:10000); Alexa FluorTM mouse 568, 594, human 594 and rabbit 633 secondary antibodies used 
for immunofluorescence (ThermoFisher Scientific; 1:500).
polotyrin discovery and synthesis. The binding poses of both PLHSpT and LHSpTA were identified by 
Yun et al.57. These structures were used as the starting point for the design of small molecule Plk1 inhibitors we 
termed phosphopeptidomimetics as they were designed to mimic the structure of LHSpT.
The formulation of de novo phosphopeptidomimetics began with the modelling of the LHSpT atomic arrange-
ment in three-dimensional space. Correct positioning of LHSpT electronic features and overall shape was enabled 
through this conceptualisation process. Small molecules were then assembled to replicate the same electronic and 
shape features of LHSpT. This technique was used to identify several structures, chemical intuition was used to 
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produce compound libraries. These libraries were docked into the prepared crystal structure of LHSpTA using the 
Schrodinger small molecule discovery suite and subsequently analysed by docking score and visually inspecting 
the docking pose. Two rounds of in silico docking and analysis were required for the discovery of small mole-
cules such as polotyrin that warranted synthetic effort. The synthesis of Polotyrin is described in detail in the 
Supplementary Methods section.
Data availability
Crystallographic data reported in this paper have been deposited in the Protein Data Bank database with 
identifiers 5NEI and 5NMM. All data, materials and associated protocols are available without restriction.
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